| Role of faecal microbiota transplantation for maintenance of remission in patients with ulcerative colitis: a pilot study A Sood, R Mahajan, A Singh, V Midha, V Mehta, V Narang, T Singh, ... Journal of Crohn's and Colitis 13 (10), 1311-1317, 2019 | 161 | 2019 |
| Use of thiopurines in inflammatory bowel disease: an update A Singh, R Mahajan, S Kedia, AK Dutta, A Anand, CN Bernstein, D Desai, ... Intestinal research 20 (1), 11-30, 2022 | 74 | 2022 |
| Diet and inflammatory bowel disease: The Asian Working Group guidelines A Sood, V Ahuja, S Kedia, V Midha, R Mahajan, V Mehta, R Sudhakar, ... Indian journal of Gastroenterology 38, 220-246, 2019 | 72 | 2019 |
| Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis A Sood, R Mahajan, G Juyal, V Midha, CS Grewal, V Mehta, A Singh, ... Intestinal research 17 (1), 78-86, 2019 | 59 | 2019 |
| Differential diagnosis of Crohn’s disease versus ileal tuberculosis A Sood, V Midha, A Singh Current gastroenterology reports 16 (11), 418, 2014 | 46 | 2014 |
| Tofacitinib in acute severe ulcerative colitis (TACOS): A randomized controlled trial: Tofacitinib in ASUC A Singh, MK Goyal, V Midha, R Mahajan, K Kaur, YK Gupta, D Singh, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 42 | 2022 |
| Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study) A Sood, A Singh, R Mahajan, V Midha, V Mehta, YK Gupta, V Narang, ... Journal of gastroenterology and hepatology 35 (3), 418-424, 2020 | 40 | 2020 |
| Clinical profile of hepatitis C virus infection in a developing country: India R Mahajan, V Midha, O Goyal, V Mehta, V Narang, K Kaur, A Singh, ... Journal of Gastroenterology and Hepatology 33 (4), 926-933, 2018 | 32 | 2018 |
| Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry A Sood, K Kaur, R Mahajan, V Midha, A Singh, S Sharma, AS Puri, ... Intest Res 19 (19), 206-216, 2021 | 31 | 2021 |
| Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019) K Dharni, A Singh, S Sharma, V Midha, K Kaur, R Mahajan, PS Dulai, ... Indian Journal of Gastroenterology 43 (1), 188-198, 2024 | 30 | 2024 |
| Clinical predictors of response to faecal microbiota transplantation in patients with active ulcerative colitis A Sood, A Singh, R Mahajan, V Midha, K Kaur, D Singh, N Bansal, ... Journal of Crohn's and Colitis 15 (2), 238-243, 2021 | 27 | 2021 |
| Impact of direct acting antiviral therapy for treatment of hepatitis C genotypes 1, 3 and 4: a real life experience from India V Mehta, R Mahajan, V Midha, V Narang, K Kaur, A Singh, A Malhotra, ... Journal of clinical and experimental hepatology 8 (1), 7-14, 2018 | 22 | 2018 |
| Trends of inflammatory bowel disease at a tertiary care center in northern India A Sood, K Kaur, A Singh, V Midha, R Mahajan, N Bansal, V Mehta, ... Intestinal research 19 (3), 282-290, 2021 | 19 | 2021 |
| Role of percutaneous catheter drainage as primary treatment of necrotizing pancreatitis V Mehta, R Kumar, S Parkash, S Singla, A Singh, J Chaudhary, H Bains The Turkish Journal of Gastroenterology 30 (2), 184, 2018 | 18 | 2018 |
| Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis V Midha, R Mahajan, V Mehta, V Narang, A Singh, K Kaur, A Sood Intestinal research 16 (1), 83, 2018 | 18 | 2018 |
| Tofacitinib versus oral prednisolone for induction of remission in moderately active ulcerative colitis [ORCHID]: a prospective, open-label, randomized, pilot study A Singh, V Midha, K Kaur, R Mahajan, D Singh, R Kaur, A Kohli, ... Journal of Crohn's and Colitis 18 (2), 300-307, 2024 | 17 | 2024 |
| Incidental benefits after fecal microbiota transplant for ulcerative colitis R Mahajan, V Midha, A Singh, V Mehta, Y Gupta, K Kaur, R Sudhakar, ... Intestinal research 18 (3), 337-340, 2020 | 17 | 2020 |
| Evaluation of nutritional characteristics reveals similar prevalence of malnutrition in patients with ulcerative colitis and Crohn’s disease A Singh, V Midha, R Mahajan, S Verma, C Kakkar, J Grover, D Singh, ... Digestive Diseases and Sciences 68 (2), 580-595, 2023 | 16 | 2023 |
| Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease A Sood, V Ahuja, V Midha, SK Sinha, CG Pai, S Kedia, V Mehta, ... Intest Res 18 (18), 355-378, 2020 | 15 | 2020 |
| Management of perianal fistulizing Crohn’s disease A Singh, V Midha, GS Kochhar, B Shen, A Sood Inflammatory Bowel Diseases 30 (9), 1579-1603, 2024 | 14 | 2024 |
Vikram NarangProfessorVerified email at dmch.edu